These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 16325333)
1. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. Su X; Vicker N; Ganeshapillai D; Smith A; Purohit A; Reed MJ; Potter BV Mol Cell Endocrinol; 2006 Mar; 248(1-2):214-7. PubMed ID: 16325333 [TBL] [Abstract][Full Text] [Related]
2. Discovery of novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. Su X; Vicker N; Trusselle M; Halem H; Culler MD; Potter BV Mol Cell Endocrinol; 2009 Mar; 301(1-2):169-73. PubMed ID: 18775471 [TBL] [Abstract][Full Text] [Related]
3. Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling. Yang H; Dou W; Lou J; Leng Y; Shen J Bioorg Med Chem Lett; 2008 Feb; 18(4):1340-5. PubMed ID: 18242087 [TBL] [Abstract][Full Text] [Related]
4. Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors. Su X; Pradaux-Caggiano F; Thomas MP; Szeto MW; Halem HA; Culler MD; Vicker N; Potter BV ChemMedChem; 2010 Jul; 5(7):1026-44. PubMed ID: 20486152 [TBL] [Abstract][Full Text] [Related]
5. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons. Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016 [TBL] [Abstract][Full Text] [Related]
6. The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibitors. Yuan C; St Jean DJ; Liu Q; Cai L; Li A; Han N; Moniz G; Askew B; Hungate RW; Johansson L; Tedenborg L; Pyring D; Williams M; Hale C; Chen M; Cupples R; Zhang J; Jordan S; Bartberger MD; Sun Y; Emery M; Wang M; Fotsch C Bioorg Med Chem Lett; 2007 Nov; 17(22):6056-61. PubMed ID: 17919905 [TBL] [Abstract][Full Text] [Related]
7. 2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice. Johansson L; Fotsch C; Bartberger MD; Castro VM; Chen M; Emery M; Gustafsson S; Hale C; Hickman D; Homan E; Jordan SR; Komorowski R; Li A; McRae K; Moniz G; Matsumoto G; Orihuela C; Palm G; Veniant M; Wang M; Williams M; Zhang J J Med Chem; 2008 May; 51(10):2933-43. PubMed ID: 18419108 [TBL] [Abstract][Full Text] [Related]
8. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors. Lee JH; Kang NS; Yoo SE Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331 [TBL] [Abstract][Full Text] [Related]
9. The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening. Schuster D; Maurer EM; Laggner C; Nashev LG; Wilckens T; Langer T; Odermatt A J Med Chem; 2006 Jun; 49(12):3454-66. PubMed ID: 16759088 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human and rat 11beta-hydroxysteroid dehydrogenase type 1 by 18beta-glycyrrhetinic acid derivatives. Su X; Vicker N; Lawrence H; Smith A; Purohit A; Reed MJ; Potter BV J Steroid Biochem Mol Biol; 2007 May; 104(3-5):312-20. PubMed ID: 17493801 [TBL] [Abstract][Full Text] [Related]
11. Distinctive molecular inhibition mechanisms for selective inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. Tu H; Powers JP; Liu J; Ursu S; Sudom A; Yan X; Xu H; Meininger D; Degraffenreid M; He X; Jaen JC; Sun D; Labelle M; Yamamoto H; Shan B; Walker NP; Wang Z Bioorg Med Chem; 2008 Oct; 16(19):8922-31. PubMed ID: 18789704 [TBL] [Abstract][Full Text] [Related]
12. Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1). Sun D; Wang Z; Di Y; Jaen JC; Labelle M; Ma J; Miao S; Sudom A; Tang L; Tomooka CS; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP Bioorg Med Chem Lett; 2008 Jun; 18(12):3513-6. PubMed ID: 18511278 [TBL] [Abstract][Full Text] [Related]
13. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds. Blum A; Favia AD; Maser E Mol Cell Endocrinol; 2009 Mar; 301(1-2):132-6. PubMed ID: 18822345 [TBL] [Abstract][Full Text] [Related]
14. Diazepane-acetamide derivatives as selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors. Odermatt A Expert Opin Ther Pat; 2009 Oct; 19(10):1477-83. PubMed ID: 19780703 [TBL] [Abstract][Full Text] [Related]
15. Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type I. Roche D; Carniato D; Leriche C; Lepifre F; Christmann-Franck S; Graedler U; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E Bioorg Med Chem Lett; 2009 May; 19(10):2674-8. PubMed ID: 19395260 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors. Stanetty C; Czollner L; Koller I; Shah P; Gaware R; Cunha TD; Odermatt A; Jordis U; Kosma P; Classen-Houben D Bioorg Med Chem; 2010 Nov; 18(21):7522-41. PubMed ID: 20851614 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Ye XY; Yoon D; Chen SY; Nayeem A; Golla R; Seethala R; Wang M; Harper T; Sleczka BG; Apedo A; Li YX; He B; Kirby M; Gordon DA; Robl JA Bioorg Med Chem Lett; 2014 Jan; 24(2):654-60. PubMed ID: 24360604 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and structural activity relationship of 11beta-HSD1 inhibitors with novel adamantane replacements. Yeh VS; Kurukulasuriya R; Madar D; Patel JR; Fung S; Monzon K; Chiou W; Wang J; Jacobson P; Sham HL; Link JT Bioorg Med Chem Lett; 2006 Oct; 16(20):5408-13. PubMed ID: 16890427 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and 11β hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group. Kwon SW; Kang SK; Lee JH; Bok JH; Kim CH; Dal Rhee S; Jung WH; Kim HY; Bae MA; Song JS; Ha DC; Cheon HG; Kim KY; Ahn JH Bioorg Med Chem Lett; 2011 Jan; 21(1):435-9. PubMed ID: 21093259 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors. Gaware R; Khunt R; Czollner L; Stanetty C; Da Cunha T; Kratschmar DV; Odermatt A; Kosma P; Jordis U; Classen-Houben D Bioorg Med Chem; 2011 Mar; 19(6):1866-80. PubMed ID: 21376605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]